Podcasts about chief executive office

This episode of We Question and Learn will feature an interview with Maggie Horne, Director of the Small Business Development Center at Gannon University. Then my guest will be Craig Palmer, Chief Executive Office of the Erie Water Works.

In August 2020, the Queensland Security Industry Workforce Development Plan was released, which identified significant challenges and opportunities from emerging technologies, evolving licensing requirements, changing workforce demographics and adjustments to training packages.Coupled with the increasing complexity of the profession and the significant role that the industry plays in keeping Queenslanders safe, the security industry faces the momentous task of maintaining day-to-day operations while scaling up in preparation for the 2032 Olympic Games.In this episode of the ASIAL Security Insider podcast, we speak with Bernie Hogan and Bryan de Caires about how the security industry can plan for what we know is coming, be ready to adapt along the way, and how can you get involved?” Mr Bernie Hogan, Jobs Queensland Board Member and Chief executive of the Queensland Hotels Association, the peak industry body representing the hotels, hospitality and tourism accommodation sector in Queensland.Bernie has enjoyed a career in advocacy, media and government, working his way up from his start behind the bar. He is passionate about his industry, the people within it, and associated industries like the security industry. Bryan de Caires is the Chief Executive Office of ASIAL (Australian Security Industry Limited), the peak body for security professionals.People interested in registering their interest in the free Grow Your Own program can visit: usc.edu.au/sesp For more information, visit www.asial.com.au

David Flemming speaks with Laurie Bladwin, Chief Executive Office with Palm Springs Opera Guild about the many programs and events coming up in the near future.

in this weeks part 2 of 2 Matt Fleury, President & Chief Executive Office of The Connecticut Science Center talks about some of the new exhibits soon to be arriving at the Science Center and how they are being used to help with STEM education. Along with allowing visitors to open up their imagination to new ideas.

in this weeks part 1 of 2 Matt Fleury, President & Chief Executive Office of The Connecticut Science Center talks about how important STEM Education is and how the Science Center is looking to get youth interested in jobs and careers that exist right here in CT.

The Roundtable Panel: a daily open discussion of issues in the news and beyond. Today's panelists are President and Chief Executive Office of The New York State Energy Research and Development Authority (NYSERDA) Doreen Harris, public policy and communications expert Theresa Bourgeois, and author and contributing writer for "Rolling Stone" Jeff Goodell.

In episode 102, chats to Roman Chiporukha, founder of SpaceVIP and co-founder of the luxury lifestyle management firm Roman & Erica. They dive deep into the burgeoning world of private space exploration, discussing the fascinating journey of introducing the final passenger to Axiom's Ax-1 mission—a $50 million ticket to the first all-private space mission to the International Space Station. Roman shares his insights on making space exploration more accessible to the private sector, the exciting future of Michelin-starred meals in space, and how celebrities and billionaires are shaping the next frontier. OUTLINE: Here's approximate timestamps for the episode. 00:14 Introduction to Episode 00:50 Origin story or not! 03:00 Axiom1 and selling a $50m ticket! 05:58 Space VIP https://www.spacevip.com/ 07:24 Experience in luxury lifestyle management 09:05 Michelin-starred meals in Space 13:44 Space Perspective https://spaceperspective.com/ 16:30 The Space Prize Foundation https://www.spaceprize.org/ 21:10 SpaceVIP Products/Experiences in the pipeline 26:30 Risks with these experiences 32:40 Celebs in Space 40:00 Final thought - WHY SPACE 41:50 Wrap Up and socials Connect with Website: https://www.spacevip.com/ X: https://twitter.com/getmaxspace Linkedin: https://www.linkedin.com/company/spacevip/ Stay connected with us! Use #Astroben across various social media platforms to engage with us! Youtube: www.youtube.com/@astrobenpodcast Website: www.astroben.com Instagram: https://www.instagram.com/astrobenpodcast/ X: https://x.com/Gambleonit Tik Tok: https://www.tiktok.com/@astrobenpodcast LinkedIn: https://www.linkedin.com/company/astrobenpodcast/

Join Sarah Noll Wilson and guest Beth Shelton as they explore the complexities of addiction and sobriety. Sharing candidly from her personal experience, Beth provides valuable insights into understanding addiction, supporting loved ones, and embracing vulnerability for personal growth and healing. About Our Guest Beth Shelton is the Chief Executive Office of Girl Scouts of Greater Iowa, overseeing all operations for 13,000 members in portions of Iowa, Nebraska and South Dakota. With thought-provoking discussions among hundreds of speeches, conferences, podcast interviews, and articles written, Beth has reached millions of people from coast to coast, on topics ranging from workplace transformation to mental wellbeing to sobriety.  Beth unapologetically speaks about the human experience and has received national accolades, highlighted on platforms ranging from Good Morning America, CNN and Working Mother Magazine, to The Washington Post, USA Today and the Today Show. Beth is persistently curious, an avid reader, and uses solution-focused leadership to encourage radical innovation. She received her BA from Simpson College and MBA from Drake University, and has been named an alumni of achievement from both, while recently completing the Artificial Intelligence certificate program at MIT. Beth, a life-long amputee, embraces a spirit of empowering others, having served various causes; including the Iowa Amputee Golf Association, leading a local Girl Scout troop, serving on her local school board, and coaching youth teams in multiple sports.  She has a lifelong love of sports, having been a 3-time collegiate MVP in tennis. She loves driving her vintage Jeep with the top off, just took up guitar lessons, and is enjoying the journey of visiting every national park.  Links and Resources Website: www.bethshelton.com This Naked Mind by Annie Grace: www.thisnakedmind.com The Substance Abuse and Mental Health Services Administration (SAMHSA): www.samhsa.gov

Welcome to another episode of IngenioUs, where we explore transformative ideas and the people behind them in higher education. Today, we're thrilled to host two remarkable leaders, Sarita Brown , Co-Founder and President and Deborah Santiago, Co-Founder and Chief Executive Office of Excelencia in Education. Over the past 20 years, Excelencia has played a pivotal role in shaping the landscape of Latino student success in American colleges and universities.  In today's conversation, Sarita and Deborah will take us through the inspiring journey of Excelencia, from its inception to becoming a national leader in advancing Latino student college completion. They'll share insights into their strategic approach to data-driven advocacy, the significant milestones they've achieved, and what lies ahead in their mission to accelerate Latino student success. Join us as we delve into how their leadership and unwavering commitment have transformed educational practices and policies, and continue to impact countless lives across the nation. --- Send in a voice message: https://podcasters.spotify.com/pod/show/chelip/message

Water Week has begun and to kick the week off we sat down with Chief Executive Office and Director of Current; Alaina Harkness and Lead Water Strategist at Argonne National Laboratory; Dr. Junhong Chen. Current is a non-profit convener of scientists, corporates, academic institutions, and local governments that has a goal of turning waste into wealth through responsible stewardship of water resources. Alaina and Junhong met with us to discuss their team's recent recognition as an NSF Regional Innovation Engine designee, the Blue economy of the Midwest, the energy-water nexus, and, of course, all things Water Week! Stream, stream, stream, the episode now! 

During the 2023 #GrantSummit hosted by the Grant Professionals Association, our cohosts interviewed a variety of leaders in the grant field. They shared their experiences, insights, and words of wisdom related to a number of themes ranging from giving back to the profession, leadership, philanthropy, professionalism, volunteering, professional development, and more. Hear key takeaways from each of our esteemed guests: Bernard Turner, GPC, Associate Professor of Social Entrepreneurship at Belmont University   Cheryl Kester, CFRE, GPC, 2023 Distinguished Fellow Awardee and Owner of The Kester Group Doris Shivers, GPC, Director of Grant Innovation and Management for Charlotte-Mecklenburg Schools Egondu Onuoha, GPC, President of the Grant Professionals Certification Institute and Vice President of Real Estate and Special Programs at the Brooklyn Hospital Jess Pettitt, Emcee of #GrantSummit, Speaker at Good Enough Now Johna Rodgers, GPC, Immediate Past President of the Grant Professionals Association and Owner of Johna Rodgers Consulting Leilani Ocasio, Grant Professionals Association Board Member and Project Manager at M. Palmer Consulting Mike Chamberlain, CAE, Chief Executive Office of the Grant Professionals Association Pat Duboise, GPC, Chair of the Grant Professionals Association Mentoring Committee and Director at Grant Initiatives Reagan Lynch, Immediate Past President of the Grant Professionals Foundation and Grant Policy Manager at Witt O'Brien's Scot Scala, GPC, 2023 Distinguished Fellow Awardee and President & Senior Consultant at Scala & Associates

Reducing methane emissions is the greatest opportunity to limit warming in the short term. With roughly 30% of current temperature increases are caused by methane, global food systems being responsible for 60% of methane emissions as a continuum from production to waste, and  80% of recent emissions have come from non-OECD countries  the methane challenge intimately linked to the International development challenge.To address this solution that are fit for purpose need to be developed. With feed additive solutions being only  applicable to 2% of global production systems other mechanisms to reduce methane are needed that do not compromise livelihoods and food security. Marcelo Mena is Chief Executive Office at the Global Methane Hub and the former Environment Minister for Chile from 2014 to 2018. Together with his team, the Global Methane Hub is bringing together philanthropic funding from the likes of Bezos Earth Fund and the Gates Foundation alongside government and private sector funds to create collaborative solutions across the Global South and the Global North.I recently caught up with Marcelo to discuss the importance of addressing methane emissions globally, the need for solutions that align with the sources of those emissions and the collaborative partnerships and funding mechanisms that must be developed to have a real impact. You can listen to our conversation here.

The first group of tourists to visit North Korea since before the COVID-19 pandemic returned home to Russia this week after a 4-day trip to Pyongyang and the Masikryong Ski Resort. NK News Data Correspondent Anton Sokolin discusses plans for more groups of Russian nationals to visit the DPRK next month, the experiences of one man who spent time at a North Korean summer camp on two separate occasions, as well as a state media report stating Pyongyang tested a new “controlled rocket artillery shell and ballistic control system” last week. Then, Senior Fellow for Korean Studies and Chief Executive Office at the Korea Economic Institute of America Scott Snyder joins the podcast to discuss his role writing about North and South Korea's foreign policies to provide context for media and analyze and assess current issues. He also talks about his latest book, “The United States–South Korea Alliance: Why It May Fail and Why It Must Not,” and areas where Washington and Seoul can work together outside defense, such as technology development, global public health, and space cooperation.  Scott Snyder (@snydersas) is set to become the new president and chief executive officer of the Korea Economic Institute of America next month. He has served as the Senior Fellow for Korea Studies at the Korea Economic Institute of America for over a decade and was previously a senior associate in the international relations program of the Asia Foundation. About the podcast: The North Korea News Podcast is a weekly podcast hosted by Jacco Zwetsloot (@JaccoZed) exclusively for NK News, covering all things DPRK — from news to extended interviews with leading experts and analysts in the field, along with insight from our very own journalists.

Rania Saadi speaks with H.E. Mohamed Al Musharrkh, CEO of Invest in Sharjah, H.E. Najla Al Midfa, CEO of Sheraa, and Andreas Sajgaschew, Chief Executive Office of Algatec Energy Systems Inc on the sidelines of the Sharjah Russia Business Roundtable about the business environment in the emirate and what makes Sharjah an ideal hub for foreign investment and trade. Listen to #Pulse95Radio in the UAE by tuning in on your radio (95.00 FM) or online on our website: www.pulse95radio.com ************************ Follow us on Social. www.facebook.com/pulse95radio www.twitter.com/pulse95radio www.instagram.com/pulse95radio www.youtube.com/pulse95radio

This week, Jennifer Dixon joins Jonathan to share the mission of The Health Foundation, which she is Chief Executive Office of. The pair discuss the resource allocation formula that was created, taking into account the needs of the population, as well as the future of national strategy in health and healthcare. They further explore underfunding in the National Health Service (NHS), and the importance of investing in community care.   Use the following timestamps to navigate the content in this episode:  (00:00)-Introduction  (02:05)-Dixon's route into medicine   (03:57)-The Health Foundation  (08:00)-Future strategies for national healthcare systems   (14:05)-'The thermostat is set too cold', Europe versus the USA   (18:32)-Dixon's publications   (24:40)-Telehealth and artificial intelligence as tools in healthcare   (26:50)-'Money is too tight to mention' and the NHS as a ‘political hot potato'  (32:24)-The highs and lows with global healthcare provision   (24:40)-Future services  (37:46)-Use of social media and Dixon's ‘a-ha!' moments   (42:08)-Dixon's three wishes 

Strategic Consortium of Intelligence Practitioners is the leading non-profit dedicated to competitive intelligence training, education, and certification. Today, the guest will grace us with his expertise in leading a successful organization with an intelligence-driven environment. Paul Santilli, the Chief Executive Office and Executive Advisory Board Chair Emeritus of the Strategic Consortium of Intelligence Professionals (SCIP), navigates through running an intelligence-based organization. He identifies three concepts that perpetual disruption illustrates in organizations. Paul also provides insights into the fundamental components of an intelligence-based organization. He emphasizes the importance of navigating the intelligence ecosystem for startups and smaller organizations. You better not miss this episode if you want to know how your organization will succeed in an intelligence-driven environment.

For our World Sickle Cell Day episode of The G Word, Marie Nugent, Community Manager for the Diverse Data initiative at Genomics England, is joined by John James OBE, CEO of the Sickle Cell Society, and Suzannah Kinsella from the James Lind Alliance. They discuss the new priority setting partnership for sickle cell and genomics, including the longer-term plan to engage communities to create space for learning and trust building, and the importance of the patient-voice in setting research agendas for the use of genomics in sickle cell disease.  By creating a 'top ten' for future research priorities set by patients, their carers, and their healthcare professionals using a trusted methodology, we aim to build trust and understanding across patients, healthcare and research to bring maximum benefit to patients through the newly developing technology that is genomic medicine in the health service. You can read the transcript here: Research-priorities-for-sickle-cell-and-genomics.docx   "It was a few years ago when I met the Chief Executive Office of Genomics England, and we had the first podcast about sickle cell. Why I remember it well is because I was arguing that why isn't there any action being taken by way of research and genomics for sickle cell... And so Marie, it was effectively a call to action. Here today talking about the Diverse Data, which is specific work to help us prioritise what the research priorities for sickle cell should be." - John James, OBE   You can also listen to the first podcast with John James and Chris Wigley.

Nicole Jeter West is the Chief Executive Office of underdog venture team, an organization on a mission to change the game of sports business with a new “pay it forward” model that invests in unique, social-impact driven business opportunities led by passionate and diverse leaders. As CEO, Jeter West is responsible for the organization's leadership, strategic vision and growth initiatives with a focus on empowering the next generation of women and BIPOC leaders to up level the entire industry. Jeter West is on a mission to create an environment that prioritizes its values and hires based on diversity of thought, experiences and talent. Encouraging and supporting curiosity will breed innovation. With more than 20 years' experience in the sports and entertainment industry, Jeter West is renowned for her ability to apply data-driven thinking to develop new business models and innovative partnership platforms, earning her reputation as an innovator, strategist, problem-solver and natural born leader. She joined underdog venture team from the LA28 Olympic and Paralympic Games, where she was the head of brand marketing and engagement. Rooted in co-creation, powerful storytelling and empowered by data insights and technology, she led the organization's cross-functional team that delivered the Games' first-ever interactive emblem and dynamic brand launch in fall 2020. Nicole focused on developing LA28's data strategy vision and building infrastructure, teams and systems to transform the future fan and athlete experience in the global Olympic and Paralympic movement. Prior to joining LA28, Jeter West was the chief marketing officer for Legends and led all aspects of worldwide marketing and communications and was a key contributor to Legends' growth across all business verticals; most notably attractions, collegiate fundraising, and hospitality. She helped launch and served on the board of the experiential agency, Edge XP – a joint venture between Productive Edge and Legends – that combined digital, physical and virtual technologies. In 2019, Jeter West was named Legends' General Manager for U.S. Olympic and Paralympic Properties, LA28's joint commercial venture, and was a critical partner in the organization's foundational year. Jeter West spent five years as the managing director of ticket and digital for the United States Tennis Association (USTA). She started her career in marketing at Madison Square Garden and the New York Knicks. She has earned Sports Business Journal's “40 Under 40” and “Power Players” honors while also being named one of Sports Illustrated's “100 Influential Black Women in Sports”. Jeter West is a graduate of the University of Delaware, where she serves on the Board for Next League and the University of Delaware's Women's Leadership Initiative. She mentors numerous young executives throughout the sports and entertainment industry and is an active member of Delta Sigma Theta Sorority Inc. She resides in New Jersey with her husband and three children. --- Send in a voice message: https://podcasters.spotify.com/pod/show/the-sports-deli/message Support this podcast: https://podcasters.spotify.com/pod/show/the-sports-deli/support

No matter where you are in your career, you'll benefit from listening to 3Q. 3Q provides a window into the careers of some of the best in the music business. Every episode is an insider's view of the realities of life as a music executive. Topics include issues of empowerment, uncertainty, trust, finances, etc; issues that will impact you both personally and professionally. The executives we interview represent every aspect of the industry including but not limited to A&R, Marketing, Music Supervision, Artist Management, Promotion, and more. About Jeff: Jeff Vaughn is a music executive and Founder and CEO of Signal Records, a joint venture with Columbia Records. Prior to the launch of Signal, Vaughn was the Chairman and Chief Executive Office of Capitol Music Group. While at Capitol, he led creative direction and operations at the company's flagship label Capitol Records while also managing CMG's broad portfolio of labels including Astralwerks, Blue Note, Capitol Christian Music Group, and it's music distribution arm, Virgin Music Artist and Label Services. Prior to his time at Capitol, he was Vice President of A&R at Artist Partner Group, then a joint venture with Atlantic Records.Vaughn is best known for personally signing and/or directly A&Ring contemporary hip hop and R&B stars like NBA Youngboy, NLE Choppa, Toosii, Don Toliver, Kevin Gates, Kehlani, Young Thug, NoCap, Queen Naija, and Kay Flock. He has also overseen releases from artists across a wide variety of genres including Halsey, Paul McCartney, Abba, Katy Perry, Niall Horan, Marshmello, and more.Vaughn began his career in the mailroom at United Talent Agency.

Recorded live at GLOBExCHANGE in Toronto in late February 2023, episode 73 features a conversation with Rob Lister, President and Chief Executive Office of Oakville Enterprises Corporation (OEC). Following the release of Electricity Canada's annual State of the Canadian Electricity Industry, Rob sat down to chat about electrification and greenhouse gas reduction challenges, the importance of leadership to address these challenges, the collaborative nature of the electricity sector, and some of the most pressing issues facing businesses today. We also discuss the breadth of OEC's operations, and the increasing importance of ESG and Indigenous reconciliation. We close the conversation with Rob's addition to the Flux Capacitor Book Club.

Between Series 1 and series 2 of 2023, we kicked off a brand new focus series – the Love Series – in celebration of love in February 2023.  This had a great response – reminding us of what made people human.  It sent one listener back to his old photo album to remind himself of his showjumping days, and others felt motivated to take up hobbies again.   Now we are back to our main series focused on investment professionals but love runs through it like a golden thread.  Love, discipline, lessons from parents.  Our guests include a former college football player, who spent time working as a prison guard before returning to university and ultimately entering the investment industry, an expert on music valuation, multiple ESG and pensions specialists and founders of fund companies - large and small.  Our Series 2 guests are:Eddie Welch, who is an alternative asset specialist at Nuveen, a role he has held since April 2021.  He previously worked as an Associate at CIM Group, focused on real estate investing, and prior to that and his degree at Ohio State University worked in a wide variety of roles and played college football, all of which we discuss in our podcast. Jennifer Grancio  is Chief Executive Office at Engine No. 1.  Engine No. 1 is an investment firm that identifies value creation opportunities in once-in-a-generation systems changes the economy is now going through. She is based in the San Francisco Area.  She previously founded and ran her own firm advising CEOs on accelerating revenue growth and prior to that was a Managing Director at Blackrock, where she led businesses and global distribution teams for close to 20 years.  She is a Board Member of the MannKind Corporation and Ethic investments. Barry Massarsky is a Partner and Co-Practice Leader, Music Economics and Valuation Services at Citrin Cooperman.  The Founder of Massarsky Consulting, which he sold to Citrin Cooperman early in 2022. He is credited with pioneering the economics of royalty cash flows in the early 1990s and together with his business partner, Nari Matsuura, developed a model to guide banks lending to music investors. Last year Massarsky Consulting valued over 300 catalogs totaling more than $6.5 billion.  Maneesha Ghiya is Managing Partner and Founder of FemHealth Ventures, a firm focused on providing investment capital to entrepreneurs focused on women's health. Investing in healthcare since 2000, Maneesha has invested via public equities, private equities and as a hedge fund specialist.  She is a Senior Advisor to ExSight Ventures, an ophthalmology-focused venture capital fund and serves on multiple boards.   Adam Saron is Founder of Clara-Pensions, a member-first consolidator of defined benefit pension schemes. He previously ran Black Ant Investment Management, a long-biased value investor, which invested in both public equities and corporate credits. Afsaneh Beschloss is the Founder and CEO at RockCreek, an investment firm which invests across diverse sectors with a special focus on climate, affordable housing and education investments in developed, emerging and frontier markets. She is on the Board of Directors of the Global Advisory Council of the Bretton Woods Committee, a Member of the Board of Directors of the Council on Foreign Relations and holds numerous other Board and Trustee roles.Kate Nevin is President and Portfolio Manager at TSWII Capital Advisors, a role she has held for over 20 years.  She is active with many industry groups (such as The Academy of Institutional Investors and Nexus) and community organizations focused on conservation and gender equality and was a Riley Diversity Fellow. She is passionate about aligning value and investing in diversity. Sarah Whitley is Chair at Future Asset, an organization which connects girls, teachers and advisors to the diversity of opportunities in asset management.  Based in Edinburgh, she was previously Head of Japanese Equities at Baillie Gifford and currently holds a number of director roles, including as External Director at Rakuten, and Chair at the Edinburgh Festival Endowment Fund. John Harney,  is a Senior Consultant with AON, where he focuses on helping pension scheme sponsors to manage pension risks and maximise potential upside.  He is based in the Oxford area.  I cam across John through mutual friends in the industry and because I was drawn in particular to his Linkedin posts that mentioned his joy in cooking and baking, which we discussed as part of the Love series as a bonus episode.  Charlotte O'Leary is Chief Executive Officer and Director of Pensions for Purpose, which exists as a bridge between asset managers, pension funds and their professional advisers, to encourage the flow of capital towards impact investment. She has had a long career in investment management, with a particular focus on pensions as well as ESG and impact investing. She is also a passionate participant in fitness competitions, which we discussed as part of the Love series as a bonus episode. Series 2 of 2023 is kindly sponsored by Beach Point Capital Advisors, an investment manager that believes in investment beyond the traditional.  It specializes in credit investments and employs a flexible, value-oriented, risk-controlled focusing on complex and less well-followed opportunities.  You can find all of our podcasts on The Fiftyfaces Hub, Apple Podcasts, Spotify or wherever you get your podcasts.  

On this episode of Catholic Forum, after a news brief from The Dialog, we will talk to Mary Jo Timlin-Hoag, Chief Executive Office of The Basilica Shrine of Our Lady of the Miraculous Medal and the Central Association of the Miraculous Medal, in Philadelphia.  Founded in the 1920s, the Shrine was recently elevated to minor basilica status.   

If you like junior resource companies transitioning from exploration to production, UBQ is exactly what you should be paying attention to, a very young company controlled by seasoned management that has big plans to become a fully operating mining outfit. Ubique's experienced management group has track record of multiple discoveries of deposits worldwide and have just pulled off a major acquisition that will propel this small, early exploration company that just got started into the next level: production, revenue and free cash flow. They are doing this through the acquisition of Namib Lead and Zinc Mining Limited, Namibia, Africa. Namibia is one of the top African countries to operate in. According to the Fraser Institute, there are 25 operating mines, producing over 100 minerals & employing around 15,000 workers. This is a pro mining jurisdiction and they just gave Ubique the green light to proceed with the transaction. Ubique is going to become a miner, possibly as soon as six months from now. Ubique has put itself in the position to potentially generate 10 to 30 Million in annual Cash Flow. Their soon to be Lead-zinc mine was built in 2018-2019 and operated until April 2020. It is as very modern operation and was put into care and maintenance due to health and safety concerns related to the Covid-19 pandemic. This is where managements experience comes into play, identifying a very undervalued asset, depressed due to non mining reasons. The Project's mine site and processing facilities consist of an underground mine developed by trackless decline and sub-level stoping to yield 500 tonnes per day of ore.The ore is fed through a conventional crushing, grinding, and floatation plant to produce zinc and lead/silver concentrates which are filtered and dried on site before trucking the concentrate 70 kms to a deep water port with container handling facilities at Walvis Bay, from where the concentrate is shipped to international custom smelters. This is and will be a revenue generating operation. The Mineral Resources statement in 2012and updated in 2017 demonstrates viability for a mine plan. Indicated is 710,300 tonnes grading 7.02% zinc, 2.40% lead and 50 g/t silver plus, and Inferred is 408,700 tonnes grading 5.96% zinc, 2.16% lead and 38 g/t silver. There are many years of production ahead. Ubique has acquired 90% control of a company with a past producing Zinc mine. It is currently on care and maintenance, however it is in great standing and only lacks an operating partner, until now. Having been been given the go ahead from the Namibian Government in support of their transaction, it now only require shareholder and regulatory approval. Have seat and listen to this great interview with Vilhjalmur Thor Vilhjalmsson, Chief Executive Office as he discusses the impact Namibian approval will have on the future of Ubique and their goal of becoming a fully operating mining outfit.

Michelle Mennillo is the Chief Executive Office of OTFC and a woman I greatly admire which is why I invited her to share her story on the Powerful Stories Podcast today.  Our paths crossed this year when she joined our Business Attraction Program and I experienced first-hand her leadership insights and gift to the world. She is a woman of her word as every day she chooses to empower others to define and live their life purpose, guide them to grow, and challenge them to be better by celebrating their legacy. Michelle believes that the power of our story begins with our childhood. Through her own life lessons, she now leads a team of 50 who transform the lives of children and parents by providing paediatric occupational therapy services to create possibilities and encouragement so that others can rise and achieve their own goals and dreams. We talk about: 1) Michelle's roadmap to success which has seen her rise up as a leader, mother and wife collaborating with likeminded humans including the power of her own story. 2) How personal and business challenges can be translated into opportunities that empower you to become the next best version of YOU. 3) What makes a good leader in today's world?  How Michelle has used this to benchmark her own leadership role at OTFC. 4) How Michelle created a framework for others to rise through facing their own challenges and empowering them to rise. What has been your greatest success story? 5) Stepping into 2023 what kind of a legacy is Michelle building for the future generation?   Where to find Michelle Linkedin : Michelle Mennillo Website: OTFC Group   Where to Find Tory: Website: https://powerful-steps.com/  Instagram: @powerfulsteps LinkedIn: https://www.linkedin.com/in/tory-archbold-b8542715/ Powerful Steps Coffee Challenge: https://powerful-steps.com/coffee-challenge/. Youtube Channel:  Powerful Steps - YouTube See omnystudio.com/listener for privacy information.

In this episode, Russ Thomas, Chief Executive Office of Availity, discusses their core business of clinical and claims data to drive better healthcare outcomes and reduce costs. Availity optimizes information exchange between two of the most critical stakeholders in the healthcare ecosystem – health plans and providers – through a single, secure network. Russ talks […]

In this episode, Russ Thomas, Chief Executive Office of Availity, discusses their core business of clinical and claims data to drive better healthcare outcomes and reduce costs. Availity optimizes information exchange between two of the most critical stakeholders in the healthcare ecosystem – health plans and providers – through a single, secure network. Russ talks […]

Welcome to another Episode of Business Chats with BNAZ!  In this episode of Business Chats with BNAZ, Brian is joines by Andy Paschke, Hotel Sales Executive and David Leonardo, Chief Executive Office at Chill-N Nitrogen Ice Cream (chilln.com).Andy, Brian and David discuss all things Branding and Customer Loyalty.  David shares his point of view through the lens of an upcoming company while Andy shares his perspective from a company with a global reach.What is Branding?  Why is it important?  How does factor into business development?Does it come into play when building a culture?How can you play a role in branding regardless of your position with a company?Customer Loyalty and when and how it comes into play on a daily basisMore on ChillNChillN Nitrogenwww.chillnicecream.com/about ***Please note all opinions expressed on The Three Guys Podcast do not represent any Group, Company or Organization***Episode Produced by The Three Guys ProductionsThe Three Guys Podcast:Instagram:  The Three Guys Podcast (@the_three_guys_podcast_) • Instagram photos and videosTwitter:  The Three Guys Podcast (@TheThreeGuysPo1) / TwitterYouTube:   Three Guys Podcast - YouTubeLinkedIn the-three-guys-podcastDerek:  Derek DePetrillo (@derekd0518) • Instagram photos and videosBrian:  Brian Nazarian (@the_real_brian_nazarian) • Instagram photos and videosBrett:  Brett J. DePetrillo (@78brettzky)

If you like junior resource companies transitioning from exploration to production then Ubique Minerals is exactly the right company be paying attention to. Ubique currently control Daniel's Harbour Zinc property in Newfoundland, a past producing project with a high grade history. In the constant search for high quality projects, Ubique started their growth spree with the 24.99% acquisition of Resource 500 V ltd in Namibia, paving the way for the next and most significant transaction in this very young company's existence. Controling Namib Lead and Zinc Mining Limited (NZLM) Ubique has taken 90% control of a company with a past producing Zinc mine, and it's ready to go back into production. What strengthens this transaction even further is management's experience. They have a track record of multiple discoveries of deposits worldwide as well as managing operations. This is a transformative transaction for Ubique and its shareholders that will propel this tiny micro-cap company into the rarified air of a producer. The cost? $20Million. A very small price to transform Ubique from exploration into a producer. Ubique is on its way to generate revenue and chart its own destiny. Ubique has the potential to generate 10 to 30 million of annual cash flow and can re-start operations in 6 to 12 months. This is a major transaction and the growth prospects are blue sky. Ubique could very well be self-sufficient in 12 to 18 months. And if you are wondering why Zinc? It is one of the most stable Base Metals and is constantly in demand. It is the fourth most common metal in use, trailing only iron, aluminum, and copper with an annual production of about 13 million tonnes. It is used in electrical batteries. About 59% of zinc is used for corrosion prevention, which includes galvanizing. 47% of the world's zinc is used for galvanizing. This is used to protect another metal, usually iron, from rusting. The zinc coating corrodes instead of the iron. Constant consumer and industrial demand make Zinc a compelling target for production. Ubique is a SmallCap company that can potentially deliver free cash flow from operations in 6 to 12 months. Combined, the case for SmallCap success has never been greater. Have seat and listen to this great interview with Vilhjalmur Thor Vilhjalmsson, Chief Executive Office as he breaks down the strategy behind this company altering decision in the SmallCap space and what to expect as the company marches toward Zinc production.

Enter into the world of grant writing. Meet Debbi Mallinson, the impact-driven Chief Executive Office and Founder of Magic Lamp Consulting. Listen in as she sheds light on her own experience of early success in fundraising that lead to her passion work for helping small and mid-sized non-profits grow with her effective grant writing techniques. If you are currently running a non-profit, you don't want to miss this episode!

Paddington Marmalade Messiness is a unique theatrical event for lovers of that iconic and inquisitive bear, Paddington, as Histrionic Productions are offering free tickets for two performances this Saturday 27 August at Dalkeith Palace, Edinburgh with live audio description and integrated touch tours. RNIB Connect Radio's Toby Davey was joined by Adam McKenzie Wylie, Chief Executive Office of Histrionic Productions to share more about this unique interactive theatre event for Paddington fans both young and old. Adam began by giving a bit of background and history to the production Paddington Marmalade Messiness, what the show is all about and who it is primary aimed at. Adam went on to say why Histrionic Productions wanted to provide two performances for blind and partially sighted people of Paddington Marmalade Messiness with live description and touch tours by professional Describer Julia Grundy.   Paddington Marmalade Messiness is on at Dalkeith Palace, Edinburgh on Saturday 27 August and more details about the production and how to book your free tickets can be found by visiting the following website -  https://paddingtonmarmalademessiness.com/edinburgh (Image shows Paddington bear in iconic red hat a blue coat peering out from behind a black piece of fabric with twinkly lights in the background. At the top of the image is written 'Paddington The Immersive Adventure' and in the bottom right corner 'Free Tickets. Audio described shoe with integrated touch tour 27th August')

Our tenth show features a lengthy interview with Chief Executive Office of the Lincoln Institute of Public Opinion Research, Inc. Lowman Henry.

Our tenth show features a lengthy interview with Chief Executive Office of the Lincoln Institute of Public Opinion Research, Inc. Lowman Henry.

On the newest episode of The R - House Radio Show, Peter Hunt had David Rust, Chief Executive Office for Say Yes Buffalo as his guest! Peter and David chatted about many different things, and to hear what they talked about take a listen to the full episode!  

The recently signed gun law, S. 2938: Bipartisan Safer Communities Act, contained a surprise dingleberry postponing a regulation designed to save seniors money on their pharmaceutical drugs by prohibiting kickbacks to an industry few have heard of: Pharmacy Benefit Managers (PBMs). This little-known but extremely powerful industry deserves much of the blame for ever rising prescription drugs costs in the United States. In this episode, Jen gives you the scoop on PBMs and how they make their money at the expense of Americans who are most dependent on medications. Please Support Congressional Dish – Quick Links Contribute monthly or a lump sum via PayPal Support Congressional Dish via Patreon (donations per episode) Send Zelle payments to: Donation@congressionaldish.com Send Venmo payments to: @Jennifer-Briney Send Cash App payments to: $CongressionalDish or Donation@congressionaldish.com Use your bank's online bill pay function to mail contributions to: 5753 Hwy 85 North, Number 4576, Crestview, FL 32536. Please make checks payable to Congressional Dish Thank you for supporting truly independent media! View the shownotes on our website at https://congressionaldish.com/cd255-pharmacy-benefit-managers-pbms We're Not Wrong Berlin Meetup Contact Justin at WereNotWrongPod@gmail.com Background Sources Recommended Congressional Dish Episodes CD134: The EpiPen Hearing US Healthcare Landscape Jessi Jezewska Stevens. Apr 23, 2020. “A Brief History of the Great American Healthcare Scam.” Bookforum. Tanza Loudenback. Mar 7, 2019. “The average cost of healthcare in 21 different countries.” Insider. Chuck Grassley and Ron Wyden. 2019. “Insulin: Examining the Factors Driving the Rising Cost of a Century Old Drug [Staff Report].” U.S. Senate Finance Committee. “Health Insurance Coverage of the Total Population.” Kaiser Family Foundation. Sara R. Collins and David C. Radley. Dec 7, 2018. “The Cost of Employer Insurance Is a Growing Burden for Middle-Income Families.” The Commonwealth Fund. PBMs What are PBMs? JC Scott. Jun 30, 2022. “Drug manufacturers are root cause of high drug costs; PBMs drive costs down.” The Hill. Zach Freed. Jun 22, 2022. “The Pharmacy Benefit Mafia: The Secret Health Care Monopolies Jacking Up Drug Prices and Abusing Patients and Pharmacists.” American Economic Liberties Project. Adam J. Fein. Jun 22, 2021. “The Top Pharmacy Benefit Managers of 2020: Vertical Integration Drives Consolidation (rerun).” Drug Channels. “Flash finding: How drug money from sick people really works.” Nov 11, 2021. 46brooklyn. Adam J. Fein. Feb 3, 2019. “Don't Blame Drug Prices on ‘Big Pharma.'” The Wall Street Journal. How PBMs Make Money “DIR Fees.” National Association of Chain Drug Stores. “How PBMs Make Money: PBM Practices & Profits.” RxSafe. True North Political Solutions. Oct 25, 2017. “White Paper: DIR Fees Simply Explained.” Pharmacy Times. ACA “Vertical Integration” Loophole Peter High. Jul 8, 2019. “A View From Inside Cigna's $67 Billion Acquisition Of Express Scripts.” Forbes. Angelica LaVito. Nov 28, 2018. “CVS creates new health-care giant as $69 billion merger with Aetna officially closes.” CNBC. David Dayen. Oct 12, 2018. “Why the Aetna and CVS Merger Is So Dangerous.” The American Prospect. Jeff Byers. April 12, 2018. “Optum a step ahead in vertical integration frenzy.” Healthcare Dive. Graph: Optum opens up wider market for UnitedHealth Group Graph: Optum's pharmacy business contributes the majority of its revenue Susan Morse. May 10, 2017. “Secret weapon: UnitedHealth's Optum business is laying waste to old notions about how payers make money.” Healthcare Finance. Lobbying “Client Profile: Pharmaceutical Care Management Assn.” Open Secrets. The Demise of Independent Pharmacies Christine Blank. Oct 17, 2019. “Independents Prepare to Close Up Shop.” Drug Topics. Paulina Firozi. Aug 23, 2018. “The Health 202: Here's why rural independent pharmacies are closing their doors.” The Washington Post. What Is a Formulary? Ana Gascon Ivey. May 19, 2020. “A Guide to Medication Formularies.” GoodRx. Previous Delays in Rebate Regulation Paige Minemyer. Jan 29, 2021. “In a win for PBMs, Biden administration delays rebate rule.” Fierce Healthcare. Paige Minemyer. Jan 12, 2021. “PCMA sues Trump administration over rebate rule.” Fierce Healthcare. “Incorporating the Effects of the Proposed Rule on Safe Harbors for Pharmaceutical Rebates in CBO's Budget Projections—Supplemental Material for Updated Budget Projections: 2019 to 2029.” May 2019. Congressional Budget Office. The Gun Law Passage Process Office of the Clerk. May 18, 2022. “Roll Call 212 | Bill Number: S. 2938.” U.S. House of Representatives. Tampa Bay Times Editorial Board. May 12, 2022. “Republican lawmakers should be ashamed for failing to honor Justice Joseph Hatchett.” Miami Herald. Annie Karni. Apr 12, 2022. “House G.O.P., Banding Together, Kills Bid to Honor Pioneering Black Judge.” The New York Times. Background on Most Important Provisions Mary Katherine Wildeman. May 26, 2022. “Data show most school shootings carried out by young adults, teens.” CT Insider. Jeffrey Pierre. May 26, 2022. “Experts say we can prevent school shootings. Here's what the research says.” NPR. The Dingleberry Erik Sherman. Jun 30, 2022. “Gun Safety Bill Extends Drug Middlemen Protection From Anti-Kickback Measure.” Forbes. Molly Rutherford. Jun 28, 2022. “Gun legislation provision puts drug supply chain profits over patients.” The Hill. Marty Schladen. Jun 22, 2022. “Deep inside the gun bill: a break for prescription drug middlemen.” Iowa Capital Dispatch. Poland Train Station Taylor Popielarz, Maureen McManus and Justin Tasolides. Mar 25, 2022. “‘The help given is remarkable': Inside the Poland train station that's become a hub for Ukrainian refugees.” Spectrum News NY1. The Law and the Regulation S. 2938: Bipartisan Safer Communities Act Senate Vote: 65-33 (All Nos GOP) House Vote: 234-193 (All Nos GOP) Jen's Highlighted PDF of S. 2938: Bipartisan Safer Communities Act Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees U.S. Health and Human Services Department November 30, 2020 Audio Sources The State of Competition in the Pharmacy Benefits Manager and Pharmacy Marketplaces November 17, 2015 House Committee on the Judiciary Witnesses: Bradley J. Arthur, R.Ph., Owner, Black Rock Pharmacy David Balto, Law Offices of David A. Balto PLLC Amy Bricker, R.Ph. Vice President of Retail Contracting & Strategy, Express Scripts Natalie A. Pons, Senior Vice President and Assistant General Counsel, CVS Health Clips 53:48 Bradley Arthur: The Big Three PBMs control almost 80% of the entire market and these PBMs have the upper hand both in negotiating the contract with the payer, as well as strongly influencing the actual plan design itself. The PBM industry typically states that they can use their economic power to harness enhanced market efficiencies, but for whom? However, the staggering annual revenues that continue to grow each year of the big three suggests that these efficiencies are going directly to their corporations' bottom lines. Small community pharmacies like mine are faced on a daily basis with the impact of the PBMs' disproportionate market power. Community pharmacies routinely must agree to take-it-or-leave-it contracts from the PBMs just to continue to serve our long-standing patients. As if that weren't enough, the PBMs also directly set the reimbursement rates for pharmacies, the very same pharmacies that stand in direct competition of some of these PBM-owned mail-order and specialty pharmacies. Therefore, it comes as no surprise that the PBMs present employer and government payers with carefully tailored suggested plans designs that steer beneficiaries to these PBM-owned entities. Drug Pricing in America: A Prescription for Change, Part I January 29, 2019 Senate Committee on Finance Witnesses: Kathy Sego, Mother of a Child with Insulin-Dependent Diabetes Douglas Holtz-Eakin, Ph.D., President, American Action Forum Mark E. Miller, Ph.D., Vice President of Health Care, Laura and John Arnold Foundation Peter B. Bach, MD, MAPP, Director, Memorial Sloan Kettering Center for Health Policy and Outcomes Clips 1:57:30 Sen. John Cornyn (R - TX): Can anybody on the panel explain to me why we have a general prohibition against kickbacks — they call them rebates — under the Social Security Act, but we nevertheless allow it for prescription drug pricing? What's the sound public policy reason for excluding prescription drug pricing from the anti-kickback rule under federal law? Douglas Holtz-Eakin: I can't explain that and won't pretend to. [laughter] Sen. Cornyn: I thought I was the only one who didn't understand the wisdom of that. Well, it's not a transparent arrangement and it does produce upward pressure on drug prices. And obviously, the negotiations between the PBM and the pharma in terms of what the net cost is, is not transparent, nor is it delivered to the consumer. Is it Dr. Miller? Dr. Bach? Peter Bach: It's delivered to the consumer indirectly through the reduction of the total cost of the benefit, but it is not delivered to the actual consumer using the drug, and that is a disassociation, that is a problem. Because it essentially reverses the structure of insurance. Lowering the total costs are people who use it the least, and raising the costs are people who use it the most, relative to if you allowed the rebate to be used at the point of sale, including all discounts. 1:59:49 Douglas Holtz-Eakin: If we had the negotiation be about the upfront price, so instead of a high list price and a rebate, you just negotiate a lower price, that would be the price that Ms. Sego would pay and insurance companies would look at that and say, okay, she's not paying as much as she used to, we're going to have to make up that money somewhere else and they might raise premiums. That means that people who don't have extreme insulin drug costs would pay a little bit more in a premium every month, and people who have extremely devastating medical conditions and high health care costs would get less costs. That's exactly what insurance is supposed to do. And so the rebate system is more than giving strange incentives on pricing. It's undercutting the purpose of insurance in general. Drug Pricing in America: A Prescription for Change, Part II February 26, 2019 Senate Committee on Finance Witnesses: Richard A. Gonzalez, Chairman and Chief Executive Officer, AbbVie Inc. Pascal Soriot, Executive Director and Chief Executive Officer, AstraZeneca Giovanni Caforio, M.D., Chairman of the Board and Chief Executive Officer, Bristol-Myers Squibb Co. Jennifer Taubert, Executive Vice President, Worldwide Chairman, Janssen Pharmaceuticals, Johnson & Johnson Kenneth C. Frazier, Chairman and Chief Executive Officer, Merck & Co., Inc. Albert Bourla, DVM, Ph.D., Chief Executive Office, Pfizer Olivier Brandicourt, M.D., Former Chief Executive Officer, Sanofi Clips 1:22:03 Albert Bourla: Adverse incentives that favor higher cost biologics are keeping biosimilars from reaching patients. In many cases, insurance companies declined to include lower cost biosimilars in their formularies because they would risk losing the rebates from covering higher cost medicines. I can't think of a more concerning example of a broken system and we need to do something about it. 1:33:35 Sen. Chuck Grassley (R - IA): So many of you have voiced support for the recent rebate rule proposed by the administration. Should the administration finalized this rule, will you commit to lowering your drug prices? Richard Gonzalez [CEO, AbbVie]: Mr. Chairman, we are supportive of the rule. We'd like to see it in its final form, obviously, to make a final decision, but we are supportive of taking the discount to the patient at the point of sale. Sen Grassley: Okay. AstraZeneca? **Pascal Soriot [CEO, AstraZeneca]**The same for us Senator, I would go one step further: if the rebates were removed from the commercial sector as well, we will definitely reduce our list prices. Sen Grassley: Okay. And Bristol? Giovanni Caforio [CEO, Bristol-Myers Squibb]: We have the same positions. Sen Grassley: Okay. Johnson and Johnson? Jennifer Taubert [EVP, J&J]: Yes, we're supportive, and that definitely would be my goal. We would just need to see the final legislation, provided that there aren't additional fees that are added into the system to compensate for the rebates. Sen Grassley: Merck? **Kenneth C. Frazier: I would expect that our prices would go down if we change the system. Again, on the commercial side as well as the Medicare side. Sen Grassley: Okay, Pfizer? Albert Bourla [CEO, Pfizer]: It is a very clear intention that we will not keep a single dollar from these rebates. We will try to move every single penny to the patients and we think if this goes also to the commercial plants that will be even better for more patients. Sen Grassley: Okay. Sanofi? Olivier Brandicourt [Former CEO, Sanofi]: Lowering list price has to be linked to better access and affordability at the counter for the patients. 1:35:20 Sen. Ron Wyden (D - OR): Is it correct that your company, and nobody else, sets the starting price for all drugs sold by Pfizer? Yes or no? Albert Bourla: It is a negotiation with PBMs and they are very powerful. Sen. Wyden: But you still get to set the list price? Albert Bourla: Yes, but we set this price and the rebate limit(?). 1:35:40 Sen. Ron Wyden (D - OR): Is it correct, when a hypothetical patient, let's call her Mrs. Jones, goes to pay for her drug at the pharmacy counter, her coinsurance is based on the price of the drug you set? Albert Bourla: It is correct in many cases. Sen. Wyden: Okay. I just want you all to know that the number one reason consumers are getting hammered, is because these list prices, which you have the last word with respect to where they are, are unaffordable. And the high prices are tied to what the consumer pays at the pharmacy counter. And all this other stuff you talk about, the rebates and the discounts and the coupons, all this other stuff is window dressing, all of that. And the fact is on Part D, 40% of the drugs don't even have a rebate. So I want it understood, particularly because I've asked you, Mr. Borla, I think you and others in the industry are stonewalling on the key issue, which is actually lowering list prices. And reducing those list prices are the easiest way for American consumers to pay less at the pharmacy counter. 2:12:45 Sen. Thomas Carper (D-DE): First is eliminating rebates to PBMs. That's the first one, eliminating rebates to PBMs. The second is value based arrangements. And the third is increasing transparency industry-wide on how you set your prices. 2:13:20 Richard Gonzalez: We clearly support providing the discount at the patient level, eliminating rebates essentially. 2:14:10 Pascal Soriot: If the rebates, as I said earlier, were to be removed from Part D and the commercial sector, we would actually reduce our list prices. 2:15:10 Giovanni Caforio: I would say that not only do we support all three elements that you mentioned, but I do believe those three elements together with the continued effort to develop a generic and biosimilar market would mean significant change, and would clearly alleviate the concerns that patients have today. 2:14:44 Jennifer Taubert: We are very supportive of all three elements that you outlined 2:15:52 Kenneth Frazier: We too support all three. 2:15:55 Albert Bourla: All three elements are transformational for our industry, will disrupt it. However, we do agree that these are the three things that need to be done and also I believe that will have significant meaningful results if we do. 2:16:10 Olivier Brandicourt: We support the three Senator, but we want to keep in mind at the end of the chain the patient has to benefit, so if rebates are removed it has to be to the benefit of patients. Sen. Thomas Carper (D-DE): Good, thanks. 2:18:10 Albert Bourla: 50% of the American people are in commercial plans and these rebate rules apply to Medicare. If the rules apply to all, definitely the list price will go down. 2:18:30 Albert Bourla: The list price is not irrelevant, it's very relevant for a lot of people because they have to pay list price during the deductible period. However if the rebate rule is applied, then they become irrelevant because the patients will not be paying the list price at the purchase point. 2:19:10 Sen. John Thune (R-SD): How would manufacturers respond if the rebate rule were finalized for government programs? I mean, what does that what does that mean for the commercial market? Albert Bourla: Senator, as I said before, all these proposals that they're discussing, [undistinguishable], eliminating the rebate rule, are transformational and will disrupt the way we do business. I don't know exactly how the system will evolve, and I really don't favor a bifurcated system. I would like to have a transparent single system across both parts. So we need to see how the whole thing will evolve. 2:25:26 Johnny Isakson (R-GA): Who sets the discount and who sets the rebate? 2:26:20 Richard Gonzalez: We negotiate with payers, so managed care and PBMs— Sen. Johnny Isakson (R-GA): You're a supplier though, so you have to go negotiate with the PBMs and those people, is that right? Richard Gonzalez: Correct, and they negotiate aggressively. Sen. Isakson: Is that pretty much true with everybody, that they're the major component between the end retail consumer price and the origin of the product? Richard Gonzalez: Yes, Senator. Sen. Isakson: Well, that seems like that's someplace we ought to focus, because that's where the distorted numbers come in. Johnson & Johnson, Janssen, in your testimony, you talked about your average list price of 8.1%, up, but an average net price change of only 4.6%. So while your gross went up 8.6, your net went down 4.6 In the same pricing period. How does that happen? If you're setting the price, how does it not go up on the bottom? Jennifer Taubert: Yeah, and in fact, in 2018, our net price actually declined 8.6%, so even more than that. The intermediaries in the system are very, very effective negotiators— Sen. Isakson: Tell me who the intermediaries are. Jennifer Taubert: Those would be the PBMs and the insurers. Sen. Isakson: …and the insurance companies? Jennifer Taubert: Right, and they set the formularies for patients. Sen. Isakson: And they're not the same. They're two different people? Jennifer Taubert: Yes, correct. 2:40:45 James Lankford (R-OK): All of you have mentioned the rebate issue has been a problem and that insurance companies and PBMs are very effective negotiators. Part of the challenge of this is, health insurance companies pay their PBM based on the quality of their negotiation skills, cutting a price off the list price. And so if a list price is higher and a rebate is higher, that also gives preference to them. So the difficulty is, as you raise list price, and the rebate gets larger, the insurance company gives that preference, making it harder for biosimilars. Am I tracking this correctly? 2:43:00 Albert Bourla: Here in the US, the penetration of biosimilars is much lower than in other places, but it is disproportional to different parts of the US healthcare system. For example, in open systems, systems where the decision maker it is a PBM, the one biosimilar we have has a market share of 5% in the US. In closed systems, in systems like Kaiser, for example, integrated healthcare systems where the one who decides has the whole cost of the healthcare system in its interest, we have 73%. 5% and 73% for the same product. I agree with what Mr. Fraser said that we need to create incentives, but I would add also that we need to break this rebate trap that creates significant disincentives for providers, and the healthcare system, and insurance companies. 3:19:25 Kenneth Frazier: If you went back a few years ago, when we negotiated to get our drugs on formulary, our goal was to have the lowest copay by patients. Today the goal is to pay into the supply chain the biggest rebate, and so that actually puts the patient at a disadvantage since they're the only ones that are paying a portion of the list price. The list price is actually working against the patient. 3:19:50 Sen. Steve Daines (R-MT): Why do we have a system today? Where you all are setting, I'll just say very, very high list prices, which is the starting point for negotiation. Why? Olivier Brandicourt: Senator, we're trying to get formulary position. With those list prices. High list price, high rebates. It's a preferred position. Unfortunately the preferred position doesn't automatically ensure affordability at the end. Kenneth C. Frazier: Senator, If you bring a product to the market with a low list price in this system, you get punished financially and you get no uptake because everyone in the supply chain makes money as a result of a higher list price. Drug Pricing in America: A Prescription for Change, Part III April 9, 2019 Senate Committee on Finance Witnesses: Steve Miller, MD, Former Executive Vice President and Chief Clinical Officer, Cigna Corporation Derica Rice, Former Executive Vice President and President, CVS Health and CVS Caremark William Fleming, Pharm.D., Segment President, Healthcare Services, Humana Inc. John Prince, Chief Executive Officer, OptumRx Mike Kolar, JD, Interim President & CEO, Senior Vice President and General Counsel, Prime Therapeutics LLC Clips Sen. Ron Wyden (D - OR): Pharmaceutical Benefit Managers first showed up decades ago, back when prescription drugs were being utilized more extensively. The PBMs told the insurance companies, “we're the ones who know drug pricing, we will handle the negotiations for you.” But there is little evidence that the pharmaceutical benefit managers have actually held down the prices in a meaningful way. In fact, most of the evidence shows just the opposite. Pharmaceutical Benefit Managers actually make more money when they pick a higher price drug over a lower price drug. Colleagues, let's remember that all the way through this discussion, benefit managers make more money when they pick a higher price drug over a lower price drug. The logic on this isn't exactly complicated, graduate-level economics. PBM profits are based on taking their slice of the prescription-drug pie. More expensive drugs means there's a bigger pie. When there's a bigger pie, [there are] bigger slices for the pharmaceutical benefit managers. 50:24 Mike Kolar: Rebates and the role they play have been key areas of focus in the drug cost debate. In our view, rebates are a powerful tool to offset high prices, which are set by pharmaceutical companies, and pharmaceutical companies alone. The fact that rebates are not offered on many of the highest cost drugs, and that studies show no correlation between prices and rebates underscore that rebates are a key to mitigating rather than causing high drug prices. We pass rebates through fully to our plans, and we believe our plans should be able to choose how to apply these rebates in ways that best serve their members and market needs by balancing premiums and cost sharing. 56:05 Sen. Chuck Grassley (R-IA): I'd like to talk about consolidation, including the recent integration of PBMs with insurance companies. Last year I wrote to the Justice Department on the issues, it reported that the three largest PBMs who are before us today now covers 71% of Medicaid, Medicare Part D enrollees and 86% of standalone Drug Plan enrollees. 57:45 Derica Rice: This is a highly competitive space. In addition to the three that you've pointed out here, CMS has noted there are over 60 PBMs across the US. Therefore, the competition, there's many options for the employers that are out there, government entities, as well as unions to choose from given their specific needs. 1:10:35 Sen. Debbie Stabenow (D-MI): So when we look at Express Scripts has 100 million Americans covered, CVS 90 million, OptumRx 65 million, Prime Therapeutics 27 million, Humana 21 million, and yet Americans still pay the highest prices in the world. Even though you are negotiating for millions of people. The VA has its own pharmacy benefit manager service, they negotiate for 9 million veterans, and they pay, on average, 40% less for the same drugs that the rest of the healthcare system pays for. Despite greater volume, you are unable to secure these kinds of low prices. With all due respect, you guys are pretty bad negotiators. Given the fact that the VA can get 40% less. And so I'd like to know from each of you why that's the case. Dr. Miller? Steve Miller [Former EVP and Chief Clinical Officer, Cigna Corporation]: Yes. Part of the equation is giving patients choice. At the VA, they actually limit their formulary more than any of us at this table do. So oftentimes, they'll have one beta blocker, one ace inhibitor. And so if it's going to get to that level of choice, then we could get better prices also. Sen. Stabenow: Let me jump in, in the interest of time. I know you create nationwide drug formularies, you have pre-authorization, you give preferred status to certain medications. So you don't use any of those tools that the VA is using? Because you do. Steve Miller: We definitely use those tools, but we also give people choice. It's crucial for both physicians and patients to have the choice of the products they want to be able to access. Many of our plans want us to have broad formularies and when you have more products, it means you move less market share. Sen. Stabenow: So basically you're saying a 40% premium gives them more choice. 1:24:30 Sherrod Brown (D-OH): If the administration's rebate rule were finalized as proposed, would you in some way be required to change the way you do business? Mike Kolar: Yes, Senator we would. John Prince: Yes. William Fleming: Yes. Derica Rice: Yes. Steve Miller: Yes. Sen. Brown: Thank you. 1:25:05 Sherrod Brown (D-OH): What percentage of prescriptions that you fill across Part D actually receive a rebate? Roughly what percentage? Mike Kolar: So Senator, approximately 8% of the prescriptions that we cover in Part D are associated with a rebate. Sen. Brown: Okay, Mr. Prince? John Prince: Senator, I don't know the exact number, I know our overall business is about 7%. Sen. Brown: Okay, thank you. William Fleming: About 7-8%. Derica Rice: Senator, I do not know the exact number but we pass through 100% of all rebates and discounts. Sen. Brown: [Grunt] Steve Miller: 90% of the prescriptions will be generic. Of the 10% that are branded, about two-thirds have rebates. So it's about seven-- Sen. Brown: 7-8% like the others. Okay. To recap, PBMs do not set drug prices. Forcing you to change the way you do business -- as the administration's rule would — will not change that fact. And while the rule might impact a small percentage of drugs and Part D that receive a rebate, it does nothing to lower costs, as your answer suggests, for the other 90% of prescriptions you fill. Most importantly, absolutely nothing in the proposed rule would require Secretary Azar's former employer or any other pharma company to lower the price of insulin or any other drug. It's important to establish that, so thank you for that. 1:41:40 Catherine Cortez Masto (D-NV): Let me ask you, Dr. Fleming, in your testimony, you say Humana's analysis of the rebate rule -- and we're talking about the administration's rebate rule now — found that approximately 17% of beneficiaries will see savings at the pharmacy counter as a result of this rule. Can you tell me a little bit more about who these people are? And what kind of conditions do they have? William Fleming: Senator, there will be a number of members who are taking brand drugs for which we get rebates and so it could vary all the way from the common chronic conditions, things like diabetes or hypertension or high cholesterol, all the way over to occasionally, not usually, but occasionally on the specialty drug side. When you think of some medications like treatments for rheumatoid arthritis, multiple sclerosis, places where there's competition. Cover Art Design by Only Child Imaginations Music Presented in This Episode Intro & Exit: Tired of Being Lied To by David Ippolito (found on Music Alley by mevio)

Welcome to another Episode of Business Chats with BNAZ!  In this episode of Business Chats with BNAZ, Brian is joines by Andy Paschke, Hotel Sales Executive and David Leonardo, Chief Executive Office at Chill-N Nitrogen Ice Cream (chilln.com).Andy, Brian and David discuss all things Branding and Customer Loyalty.  David shares his point of view through the lens of an upcoming company while Andy shares his perspective from a company with a global reach.What is Branding?  Why is it important?  How does factor into business development?Does it come into play when building a culture?How can you play a role in branding regardless of your position with a company?Customer Loyalty and when and how it comes into play on a daily basisMore on ChillNChillN Nitrogenwww.chillnicecream.com/about

In this episode of The Private Practice Podcast, you're going to learn how making clinical supervision a part of your private practice can help you uplevel your business and career growth.   The trouble is, with the current associations available to therapists and confusing state licensing protocols, it can be hard for supervision-seekers to find a supervisor with whom they resonate.   After all, new graduates are looking to start their careers off on a solid foundation, and a great supervisor can truly impact the trajectory of their careers as mental health professionals.   But someone is solving the problem by connecting supervision-seekers with supervisors across the United States…   Enter Dr. Amy F Parks.   Dr. Parks is a licensed therapist with more than 35 years of experience in the mental health field. She is an LPC and a Nationally Accredited ClinicalSupervisor.   She's also the creator of The Clinical Supervision Directory.   The Clinical Supervision Directory (CSD) is the first directory of its kind in the mental health profession. Previously, mental health professionals like LMFTs, LCPs, and LCSWs relied on inadequate, often piecemeal, information when searching for a clinical supervisor to begin practicing therapy   The CSD changes the old ways of searching for supervision completely by providing a one-stop-shop for supervision-seekers to research and find the supervisors that are best for them. In This Episode, You'll Learn: The story behind The Clinical Supervision Directory and why Dr. Amy created it The biggest challenges new therapists face when trying to find the right clinical supervisor How clinical supervision can be the next step for your career development Ways to get your name out there so you can find supervisees and grow your clinical supervision How joining The Clinical Supervision Directory can help improve your SEO and social proof, helping you be seen as an expert in your field Email Dr. Amy for A Discount Code If you'd like to list yourself as a supervisor on The Clinical Supervision Directory, email hello@the-csd.com for a special discount code available for The Private Practice Elevation Podcast listeners. Subscribe & Review in Apple Podcasts If you're not yet subscribed to the podcast I want to encourage you to do that today. This is the best way to make sure you don't miss an episode! Click here to subscribe on iTunes.   And if you're feeling extra generous, I'd love to hear what you think about the podcast. Reviews help others find the podcast plus I'd really love to hear what you think! Click here to leave a review. Just click on “Ratings & Reviews” then “Write a review.” Let me know what you like best about the podcast. Thank you!   Links mentioned in this episode:  The Clinical Supervision Directory About Dr. Amy F Parks Dr. Parks is a licensed therapist with more than 35 years of experience in the mental health field. She is an LPC and a Nationally Accredited Clinical  Supervisor.   Areas of Interest: Children, Teens & Families Owner/Clinical Director @ The Wise Family, Counseling, Assessment &Education in Northern Virginia www.thewisefamily.com Licensed Professional Counselor, Virginia PhD, Educational Psychology, specialty Developmental Neuroscience Adjunct Professor, TCSPP  Clinical Supervisor, HCA Health Systems  Chief Executive Office, CSD Launched July 1, 2021 (conceived Nov 2020)Planned partnership with ACA's 55,000 members and 460 CACREPUniversities nation-wide hello@the-csd.com  

Sometime in 2021, I had the rare opportunity of visiting the Institute of Human Virology Nigeria (IHVN)Institute of Human Virology Nigeria (IHVN) was established in 2004 as an affiliate of the Institute of Human Virology, University of Maryland School of Medicine. It was incorporated in March 2004 as a local non-governmental organization with a Board of Directors. PicturesHowever, the inception of IHVN started with Dr. William Blattner and Dr. Alash'le Abimiku, both working at the National Institute's of Health and conducting early studies to track the emerging HIV epidemic in Nigeria. In 1995, Dr. Blattner in partnership with Dr. Robert C. Gallo and Dr. Robert Redfield  co-founded Institute of Human Virology (IHV), University of Maryland School of Medicine, Baltimore. Drs. Blattner and Abimiku successfully competed for international funding from the US Military, the Bill and Melinda Gates Foundation and the Centers for Disease Control (CDC) AIDS Program for a University Technical Assistance Program (UTAP) award to support the establishment and growth of IHVN.  Since 2004, the US President's Emergency Plan for AIDS Relief (PEPFAR) has supported the AIDS Care and Treatment in Nigeria (ACTION) project and follow-on grants, ACTION Plus, ACTION PlusUp and Action to Control HIV Epidemic through Evidence (ACHIEVE) projects.  http://ihvnigeria.org/about-us/our-history/I had an amazing time with the Chief Executive Office, Dr. Patrick Dakum who gave me a detailed mind tour of the organization on what they do and their economic importance.Take a listen   Support the show

Russell Benaroya / Author of One Life to Lead, Co-Founder & Partner of Stride Services Russell Benaroya is an entrepreneur with a background in corporate finance and private equity. Prior to becoming a Partner at Stride, Russell was the Senior Vice President of Corporate Development for higi, a population health enablement company that owns the largest national network of health screening stations. In 2017, higi acquired EveryMove, a venture-backed technology start-up where Russell was the co-founder and CEO. Prior to EveryMove, Russell was the Co-Founder and Chief Executive Office of REM Medical, a multi-state sleep disorder health care business that was acquired in September 2009. Prior to REM Medical, Russell was an investment professional for the private equity firms Kline Hawkes and Blue Point Capital, where he invested in healthcare, technology, and industrial based enterprises. Russell was also an early employee at Overture Services (acquired by Yahoo in 2003), a pioneer in web-based search engine marketing. Russell started his career in New York at Salomon Smith Barney as a Corporate Finance Analyst. Russell received his MBA with highest honors from the UCLA Anderson Graduate School of Business. He was awarded the Puget Sound Business Journal's 40 Under 40 Award in 2009. Russell is on the board of the Seattle Jewish Community Center and an active investor in technology start-ups. He is also an instructor in Healthcare Innovation at the University of Washington and a mentor for TechStars. When not helping other entrepreneurs succeed, he is contemplating life on 24 hour+ ultra trail runs. https://youtu.be/Jp_7NzfssFI Dan Weedin / First Underwriters Insurance Brokers (Host) Michelle Bomberger / Equinox Business Law Group (Co-Host) Russell Benaroya / One Life to Live, Stride Services (Guest)

Matt Fain is the Chief Executive Office at popcapacity. Matt has over a decade of experience in the transportation industry, and provides a phenomenal perspective into a massive problem that they solve with popcapacity. popcapacity™️ offers frictionless 3PL warehousing and fulfillment capacity by leveraging marketplace style technology and AI! Make sure to follow Matt and popcapcity on social media! 

#CustomerLoyalty #BrandLoyalty #ecommerce #cxBuilding customer and brand loyalty is every company's first challenge. This holds true especially in the highly competitive world of e-commerce as well as in brick-and-mortar retail. Charlie Cole, CEO of FTD, a 110-year-old retail and ecommerce brand, explains how he builds customer trust and brand loyalty in his organization.The conversation goes beyond customer service to focus on core aspects of business transformation and digital customer experience, looking across all touch points of the customer journey.The discussion includes these topics:-- About FTD-- On customer loyalty and customer experience-- On the components of customer experience-- On the building blocks of customer loyalty-- On the technology elements and martech stack used to create customer loyalty-- On how to understand the customer-- On the future of technology for creating customer loyalty-- On how to build customer trust that leads to loyalty-- On advice for creating customer loyalty and brand loyaltySubscribe to our newsletter to get notified of new shows: https://www.cxotalk.com/subscribeRead the complete transcript and see more: https://www.cxotalk.com/episode/ceo-perspective-how-build-customer-loyalty-2022Charlie Cole is Chief Executive Office of FTD, the modern florist collective, where he oversees people and operations. Before joining FTD, Charlie served as the first Global Chief eCommerce Officer for Samsonite while simultaneously serving as Chief Digital Officer for Tumi.

Teresa Stivers has worked in the child welfare space for nearly two decades and has served as Chief Executive Office for Walden Family Services for more than 10 years. During her tenure with the organization, Teresa has led Walden through successful accreditations from CARF, the independent agency whose evaluations of health and human services organizations is internationally recognized as the gold standard of care; twice earned Human Rights Campaign's highest innovator seal of recognition “All Children–All Families” for providing culturally competent services for LGBTQ children/families; and expanded transitional housing services, making Walden the second-largest provider in Southern California.   Prior to Walden, Teresa was with the Child Abuse Prevention Foundation where she served as Program Director and Executive Director. Her commitment to foster children in San Diego County has helped launch and establish many signature programs, including the Guardian Scholars Program and Mary's House, a transitional living program for former foster youth.   Teresa currently serves on the Executive Committee for the University of California, San Diego Chancellor's Community Advisory Board. Most recently she was a member of the Steering Committee of the Clinton Foundation Strong Families, Thriving Committees Task Force working to eliminate systemic racism in the Child Welfare and Juvenile Justice System in San Diego County.

The Bambu fund is among the first firms in the Latin American Caribbean (LAC) region authorized to issue a security token in an initial public offering on the Jamaica Stock Exchange. Bambu Coliving®. It is a community living concept for individuals aged 55+ with interests to live, work and play together; its first iteration is specific to the Caribbean. To share all about the Bambu Fund and investment opportunities in health and wellness in Jamaica is Patrick Barclay, Chief Executive Office of Bambu Fund. Some of what we looked at were: What the Bambu Fund as a company all about About the health and wellness sector...why Jamaica? When can investors expect to have access to the IPO? And lots more. Connect with Patrick Barclay: Email: pbarclay@bambufund.com Website: http://www.bambufund.com Thanks for listening to The Jamaica Stock Exchange & You, a podcast of the Jamaica Stock Exchange with your host, Heneka Watkis-Porter! Send us your feedback at podcast@jamstockex.com or on social media @jamstockex. In the meantime, follow this podcast on your favourite podcast app. The Jamaica Stock Exchange & You is produced by Heneka Watkis-Porter of The Entrepreneurial You podcast and now TV show aired on Business TV, you can find out more at henekawatkisporter.com to hear leadership and entrepreneurship lessons from guests like Zachary Harding, Les Brown, Richard Branson, Marcia Forbes, Seth Godin and more. I am also on social media at Heneka Watkis-Porter. That's all for now, see you next week! Remember, as Warren Buffet says, "Rule number one: Don't lose money. Rule number two: Don't forget rule number one.” --- Send in a voice message: https://anchor.fm/jamstockexpodcast/message

Name:Amanda ToblerCurrent title:CEOCurrent organisation:Community Services #1Amanda is the Chief Executive Office at Community Services # 1.  She has worked in the Community Sector for over 25 years, with her first management role when she was 20 years of age leading a team of 15 people.  Her key strengths are in her diverse experience and high level understanding of the not-for-profit, Government and corporate sectors.  She has high level strategic thinking capabilities and vast experience in advocacy and considerable commercial experience. Amanda has an exceptional ability to achieve results in demanding and challenging environments and an ability to build excellent relationships at all levels.Amanda has strong academic qualifications including a Degree in Community Education, an Advanced Diploma of Management and a Diploma of Government.

Albert Bourla, is a Greek veterinarian and the chairman and Chief Executive Office of Pfizer. He sits down with Armstrong Williams to discuss the efficacy of the vaccine and the importance of getting the vaccine to those able to take it. Be sure to: 1) Like and share! 2)Leave us 5 Stars & a Review on iTunes! Subscribe to The Strongcast on iTunes at: podcasts.apple.com/us/podcast/the-…1299887231?mt=2 on Stitcher at: www.stitcher.com/podcast/armstron…s/the-strongcast on Soundcloud at: @thestrongcast on YouTube at: www.youtube.com/arightside on Facebook at: www.facebook.com/realarmstrongwilliams Find out more about Armstrong and #TheStrongCast at: www.armstrongwilliams.com/strongcast strongcastpodcasttalibanafghanistanbiden

Today's podcast guest is Abdul Baaghil. We know each other from our Park Hyatt Los Angeles days together, years ago. We discuss: Experiential Travel Natural Reserves Remembering "how you make people feel" Humanizing hotels Making everyday count Enjoying time as a luxury As the Co-Founder and Chief Executive Officer of Harvest Cotton Tale ( Hospitality Group ), Baaghil's expertise includes hotel and restaurant concept creation, development and management with over 20 years of experience in Executive/GM positions with some of the industry's luxury hotel group's such as Park Hyatt in ( San Francisco and Los Angeles ), The St. Regis ( New York City ), The Ritz-Carlton Hotel Company, ( Middle East and Asia Pacific ) and Fairmont Hotels & Resorts. Prior to joining forces with Bruno Contreras in 2016 to form Harvest Cotton Tale ( Hospitality Group )in Lisbon. Baaghil served as Managing Director to a privately owned OB Hotels & Restaurants a subsidiary of Challenger Limited a leading drilling and oilfield company in North Africa and the Gulf region.

Gideon Taylor, new Executive Vice President and CEO of the Jewish Community Relations Council speaks with NYC Councilmember Farah Louis and Carine Jocelyn, Chief Executive Office of Diaspora Community Services on what the community is doing to help those affected by the recent earthquake in Haiti.

What we love so much about this episode of A Revolution in Education podcast is the apparent respectful, collegial and caring relationship evidenced in the back and forth conversation between Antonio Boyd, Executive Vice President at Future of School, and Zelda Waymer, President and Chief Executive Office at South Carolina Afterschool Alliance.  These two have been working in South Carolina and beyond for years in the best interest of youth, with a specific interest in providing learning experiences that will propel youth in disadvantaged communities.  In this conversation, they hit upon the importance of relationships in forging partnerships that are mutually beneficial and extend beyond the usual give and take.  Antonio also tells of his many years galvanizing efforts to extend youth's opportunity.  And Zelda shares her years of work galvanizing political support of her efforts, as well as a once fleeting interest in starting a trucking business.  In the end, they give Chris “finger snaps” for his proclamation that this effort to transform our systems to better support and create opportunity for all youth is a civil rights movement.  Let's GO!  Finger snaps all around for those doing the important work for all youth, like Antonio and Zelda in South Carolina.About The RevolutionariesAntonio BoydZelda Waymer

Dawn Brolin is a certified public accountant, fraud examiner, and the Chief Executive Office of Powerful Accounting, a nationally recognized accounting, tax, and consulting firm. Dawn has in-depth accounting and business expertise, working in the field for more than nineteen years. She is a QuickBooks expert, a former member of the Intuit Accountant Advisory Council, and a speaker with an entertaining style at webinars and live conferences. She has a Bachelor's degree in Business Administration and a Master's in accounting from the Eastern Connecticut State University. Her accolades include being named Top 25 Most Powerful Women in Accounting and selected as a Top 40 Under 40 by CPA Technology Magazine in 2009. Dawn joins me today to discuss the Paycheck Protection Program loans and small business finances in light of the COVID pandemic. Dawn discusses the problems surrounding the first release of PPP loans and why many sole proprietors did not get access to PPP support. We discuss doing things the right way going forward, including financial reporting and bookkeeping, and having a legitimate business with a business bank account and EIN. Dawn shares the paperwork that every business should hold in a permanent store and where you can find bookkeeping services at an affordable price. She also discusses taxes on self-employed unemployed payments and what you need to consider if you are contemplating making a 401k withdrawal. “The world will never, ever be the same after COVID. Period. And because of that, if you're a small business owner, you need to change the way you approach your business.” - Dawn Brolin This week on the SmallBizChat Podcast: Resources Mentioned: Connect with Dawn Brolin: Fix Your Business! Are you ready to run your business with intention? Ready to create a business that allows you to live your dream life and take those dream vacations you deserve? Then you need a copy of my latest book: Fix Your Business: A 90-Day Plan to Get Back Your Life and Remove Chaos From Your Business. Fix Your Business gives you concrete advice on the problem areas many small business owners face as well as the step-by-step process to find solutions so you can live the life of your dreams. It's time to take back control of your business and change how your business is run. Order your copy of Fix Your Business and design your business - and life - with intention. Let's End Small Business Failure - Together! Thanks for tuning into this week's episode of the SmallBizChat Podcast - the show on a mission to improve small business success. If you enjoyed this episode, head over to Apple Podcasts, subscribe to the show, and leave us a rating and review. Help us spread the word and end small business failure by sharing your favorite episodes with your friends and colleagues on social media. Visit our website or follow us on Facebook, Twitter, LinkedIn, Instagram, or YouTube for more great content, tips, and strategies to improve your small business.See omnystudio.com/listener for privacy information.

Get inspired to start that new business or that new idea when you are over 50! You will love how JaDee is always asking “what's next”. From flight attendant, to real estate broker, jewelry maker, marketing consultant, website developer and now t-shirt designer and Chief Executive Office of  AT PEACE TEES!Jadee was given the download for her company ten years ago and while this baby incubated, life continued to happen and she continued to help others with their dreams and visions. Fears tried to pop up specifically the fear of loss. As she saw others succeeding online and comparing to their progress and made the decision that she would do something every day.  “Every day if you are doing something you are doing something. The worst thing you can do is stop and stand still”. So what did she do?She set a launch date! Yes!  A LAUNCH DATE! Setting a date got rid of the “shoulda couldas”. It is ok if everything is not in place, but it gets the ball rolling! SET A LAUNCH DATE! It will get the ball rolling.As if that weren't enough, she started WEAR TO GIVE, a company that gives back to community. If you have an event that you want tshirts made for then she will make them and a % of the proceeds will go to the foundation or non-profit.  Charity Water is her charity of choice as they give 100% of the donations to bring clean water to those in need.Support the show (https://www.patreon.com/THEFORREALLIFE)

As Founder of the Anshara Method, Sherry Anshara utilizes her experience and expertise as a Consciousness Expert, Medical Intuitive, and Spiritual Advisor as the foundation to her groundbreaking work with Cellular Memory. The Anshara Method process is utilized to reveal Cellular Memories that often hold the root cause of your symptoms—whether mental, physical, or emotional. Sherry Anshara has created systematic processes to rid you of limitations, restrictions, negative thoughts, and toxic behavior that can be caused by information and experiences that have been recorded, or imprinted, at the Cellular level since conception. The primary goal of the Anshara Method is for people to experience healing and abundance by engaging one's Cellular Memories, and then revealing why they are the cause of one's conditions. Once the cause of one's conditions are understood, Sherry guides you through the healing of these memories by teaching you how to use the Anshara Method so you can start enjoying accelerated healing and abundance in every area of your life. Sherry Anshara is an international bestselling author, professional speaker, radio personality and contributing writer to national publications on the subject of the Anshara Method and overall wellness. ========================== Hey there….Don't forget Your part of the contract with the Universe! There is so much discussion and speculation about the Law of Attraction that the concept can sometimes get confusing if you are not sure what you are asking the Universe to do for you. Remember a contract is a two way agreement. First you must be absolutely clear what you are expecting the Universe to provide for you. And most importantly do you understand your part of the bargain? Don't forget you are part of the deal. What happens when you “think” that the Universe is not fulfilling its end of the bargain? Do you really think the Universe would not give what you are asking? Could it be you didn't understand or forgot your part of the transaction? You must be clear that the contract is in concordance with what you asked. imagesRealize with “real eyes” that you have to step up the plate and do your part of the transaction. And it is definitely a transaction, an exchange of energy. You can do all the intending, all the wishing and wanting, and all the hoping and praying and think you have lived up to your part of the contract. This is a Third Dimensional/Duality driven organization here. You are the head honcho and Chief Executive Office of your organization. The Universe is your working partner. The clue here is working, which means you have to do the “work” here. You are the one who must keep focused and on track with a clear business plan to accomplish your job, institute your promotions and keep the revenue flowing to support your plan. The Universe is your Operations Director, awaiting your clear directions. Your Director puts the puzzle pieces together for you. You have to show up for work. Wishing and wanting, hoping and needing are not clear directives. Sitting back and waiting for the Universe to move you forward is not an effective method for activating the power of your Operations Director. If your conscious and the use of your energy are focused and clear, the contract is effective. If you are confused and “wanty-needy”, this low based frequency and vibration of consciousness will make the significant difference in what you manifest through your partnership with the Universe. This Third Dimensional world requires co-participation. This is a two way contract requiring your action to implement your plan. You can hope, wish and want all day long, waiting for something more to happen or change. In this venue, your must remember the Universe has incredible patience and can out last you in the waiting process. Don't forget the re-incarnation clause in your contract! This is the lifetime to get your business plan in order and forget the busy-ness plan that takes you of course from achieving your dreams, goals and objectives. Stay out of the trauma dramas. Don't waste your valuable time. In a continuous continuing continuum, you incarnated here to consciously create an effective, prosperous life, whatever that means to you. You are the Earth plane physical manifesting half of the contract. Forget the past, it is only a reference point for what you have learned from the contracts process. Where your life didn't work, you learned, now move on. Where it worked, expand upon it. Stop waiting, get moving, and take the action. Be the take charge Chief Executive Officer, provide clear directives, the Universe is ready for you.